Evidence map›Paper›PMID 31574991›Full record

ReviewMolecules (Basel, Switzerland)2019

Recent Achievements in Medicinal and Supramolecular Chemistry of Betulinic Acid and Its Derivatives

Uladzimir Bildziukevich, Zülal Özdemir, Zdeněk Wimmer

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Uladzimir BildziukevichInstitute of Experimental Botany of the Czech Academy of Sciences, Isotope Laboratory, Vídeňská 1083, 14220 Prague 4, Czech Republic. vmagius@gmail.com.
Zülal ÖzdemirInstitute of Experimental Botany of the Czech Academy of Sciences, Isotope Laboratory, Vídeňská 1083, 14220 Prague 4, Czech Republic. zulalozdemr@gmail.com.
Zdeněk WimmerInstitute of Experimental Botany of the Czech Academy of Sciences, Isotope Laboratory, Vídeňská 1083, 14220 Prague 4, Czech Republic. wimmer@biomed.cas.cz.

Funding

Ministerstvo Průmyslu a Obchodu FV10599
6 · The paper itself

Abstract

The subject of this review article refers to the recent achievements in the investigation of pharmacological activity and supramolecular characteristics of betulinic acid and its diverse derivatives, with special focus on their cytotoxic effect, antitumor activity, and antiviral effect, and mostly covers a period 2015-2018. Literature sources published earlier are referred to in required coherences or from historical points of view. Relationships between pharmacological activity and supramolecular characteristics are included if such investigation has been done in the original literature sources. A wide practical applicability of betulinic acid and its derivatives demonstrated in the literature sources is also included in this review article. Several literature sources also focused on in silico calculation of physicochemical and ADME parameters of the developed compounds, and on a comparison between the experimental and calculated data.

Indexed as

Chemical PhenomenaBetulinic AcidHumansPentacyclic TriterpenesPhytochemicalsStructure-Activity RelationshipTriterpenesBetulinic AcidPentacyclic TriterpenesPhytochemicalsTriterpenesADME parametersantitumor activityantiviral activitybetulinic acidcytotoxicityphysicochemical parametersstructural modificationsupramolecular self-assembly

Identifiers

PMID31574991
PMCPMC6803882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.